Cambridge biomedical campus has just welcomed a new state of the art hospital, as final touches approached completion. The Royal Papworth Hospital, which will house five operating theatres, five catheter laboratories (for non-surgical procedures) and two hybrid theatres, was delivered by Skanska.
“We’re delighted to hand over the building to our customer. We look forward to watching its transformation with the latest medical equipment into a world-class facility. The thousands of hours of work by our people and the supply chain will leave a positive lasting legacy for Cambridge, the UK and beyond,” commented Charlie Norris, Project Director for Skanska.
Patients will benefit from approximately 310 beds, including a 46-bed critical care unit, with most patients having their own single, en-suite rooms. Other key features include a specialist air filtering system in the hospital’s cystic fibrosis department to minimise the spread of airborne infections, and a link corridor to the adjacent Addenbrooke’s Hospital to support the transfer of patients needing treatment in the two hospitals.
Royal Papworth staff will move from their existing hospital in Papworth Everard to the new facility, which will continue to enable staff deliver excellent care to patients suffering from heart and lung disease.
“It is incredibly exciting to be able to walk through the hospital without hard hats and high-vis jackets and really imagine this impressive building as a fully-functioning heart and lung hospital. After many years of planning, we are now just months away from moving in and starting to realise the huge benefits that the new building and its location on the Cambridge Biomedical Campus will bring for our patients and staff,” said Stephen Posey, Chief Executive at Royal Papworth Hospital NHS Foundation Trust.
All of Royal Papworth’s clinical services will be moved to the new facility during a three-week move period from 23 April 2019.